Levita Magnetics

Levita Magnetics

paid

Levita Magnetics pioneers the MARS™ platform, the world's first AI-guided autonomous surgery system using magnetic technology for minimally invasive procedures.

About

Levita Magnetics is a Mountain View, California-based medical technology company developing the MARS™ (Magnetic Autonomous Robotic Surgery) platform — the world's first AI-guided autonomous surgical system. By combining the power of magnets with machine intelligence, Levita enables a new generation of minimally invasive surgery that prioritizes patient safety, surgical precision, and procedural efficiency. The MARS platform represents a landmark innovation in surgical robotics. Its AI-driven camera guidance system autonomously tracks and adjusts the surgical field, reducing the burden on OR teams and enhancing the consistency of high-volume procedures. The system was validated in a landmark case in Santiago, Chile, marking the first autonomous AI-guided surgery in the world. Levita's Magnetic Surgery® technology replaces traditional trocars and rigid instruments with magnetically controlled tools that operate through smaller incisions, significantly reducing patient trauma, recovery time, and complication risk. The platform is designed for integration into existing surgical workflows, making advanced robotic and autonomous capabilities accessible to a broader range of surgical centers. Levita Magnetics is targeted at hospitals, surgical centers, and healthcare systems seeking to modernize their operating rooms with cutting-edge autonomous AI and robotic technologies. With a portfolio of patents and a patient-centered philosophy, Levita is positioned at the frontier of the future of surgical care.

Key Features

  • AI-Guided Autonomous Surgery: The MARS™ platform uses artificial intelligence to autonomously guide the surgical camera, improving precision and reducing the manual workload on surgical teams.
  • Magnetic Surgery® Technology: Proprietary magnetically controlled surgical instruments eliminate the need for traditional trocars, enabling smaller incisions and less invasive procedures.
  • Minimally Invasive Design: The platform is engineered to minimize patient trauma, reduce recovery time, and lower the risk of surgical complications compared to conventional methods.
  • OR Workflow Integration: Designed to integrate seamlessly into existing operating room workflows, making advanced autonomous capabilities accessible to high-volume surgical centers.
  • Clinically Validated Outcomes: Validated through landmark cases including the world's first AI-guided autonomous surgery in Santiago, Chile, demonstrating real-world safety and efficacy.

Use Cases

  • Performing minimally invasive abdominal surgeries with AI-guided autonomous camera control to reduce OR team fatigue and improve precision.
  • Enabling high-volume surgical centers to standardize and streamline laparoscopic procedures using magnetic instrument guidance.
  • Reducing patient recovery time and post-operative complications in elective and urgent surgical cases through smaller incisions.
  • Integrating autonomous AI surgical assistance into existing OR workflows without requiring complete infrastructure overhaul.
  • Advancing surgical research and clinical validation of AI-driven autonomous robotic surgery in real-world hospital environments.

Pros

  • First-of-its-Kind Technology: MARS™ is the world's first AI-guided autonomous surgical platform, placing Levita at the cutting edge of medical robotics innovation.
  • Improved Patient Outcomes: Magnetic and AI-driven minimally invasive techniques reduce patient trauma, scarring, and recovery time compared to traditional surgery.
  • Reduced OR Team Burden: Autonomous AI camera guidance lowers cognitive and physical demands on surgical staff, allowing them to focus on critical decision-making.

Cons

  • Enterprise/Hospital-Only Access: The platform is designed exclusively for hospital and surgical center deployment, making it inaccessible to individual practitioners or small clinics.
  • High Capital Investment: As a sophisticated robotic and AI surgical system, the MARS™ platform likely requires significant upfront investment in hardware and training.
  • Early-Stage Adoption: As a novel autonomous surgical platform, broad clinical adoption and long-term outcome data are still being established.

Frequently Asked Questions

What is the MARS™ platform?

MARS™ (Magnetic Autonomous Robotic Surgery) is Levita Magnetics' flagship surgical platform that uses AI-guided autonomous camera control and magnetic surgical instruments to perform minimally invasive surgery.

How does Magnetic Surgery® work?

Magnetic Surgery® uses magnetically controlled instruments that are guided through the body without traditional trocars, allowing surgeons to operate through smaller incisions with greater precision and less patient trauma.

Has MARS™ been used in real surgeries?

Yes. A landmark autonomous surgery was performed in Santiago, Chile, marking the world's first AI-guided autonomous surgical procedure using the MARS™ platform.

Who is Levita Magnetics' technology designed for?

The technology is designed for hospitals, surgical centers, and healthcare systems looking to adopt cutting-edge robotic and AI-driven surgical capabilities for high-volume procedures.

Where is Levita Magnetics headquartered?

Levita Magnetics is headquartered in Mountain View, California, and can be reached at [email protected].

Reviews

No reviews yet. Be the first to review this tool.

Alternatives

See all